inquisite.ai: Revolutionizing Clinical Trial Planning with AI

inquisite.ai is an advanced AI-powered platform designed to transform clinical development by enabling biotechs and CROs to design, plan, and execute more precise, efficient, and successful clinical trials. Leveraging a proprietary biomedical knowledge graph that connects millions of trials, research papers, and patents, along with machine learning models trained on real-world clinical data, inquisite.ai delivers data-driven insights to optimize trial design. The platform streamlines regulatory workflows by automating document creation and filing processes, while also providing powerful tools for synthesizing research evidence and generating literature reviews. With secure, collaborative workspaces, it fosters seamless teamwork between sponsors, CROs, and CDMOs, significantly reducing time and cost while boosting success rates.

Key Features:

• Proprietary Biomedical Knowledge Graph integrating millions of trials, papers, and patents
• AI-Driven Clinical Trial Optimization using machine learning models trained on real trial data
• Predictive Trial Planning for smarter, data-informed decisions
• Automated Regulatory Document & Filing Generation
• AI-Powered Research Synthesis and Literature Review Building
• Secure, Collaborative Workspaces for Sponsors, CROs, and CDMOs
• Reduced Trial Design Time and Cost
• Increased Likelihood of Clinical Trial Success

Pricing: inquisite.ai offers a freemium model with access to core features for free, and premium plans available upon request for advanced capabilities and enterprise use.

Conclusion: inquisite.ai is a transformative tool for clinical development, combining deep biomedical intelligence with automation to accelerate and enhance trial planning—perfect for biotech innovators and clinical research teams aiming to deliver better outcomes faster.